The study compared five strategies: reducing the dosage of the iodinated dye alongside less tube voltage, weight-based dosage, using unenhanced CT instead of contrast CT if it’s safe, a combination of the first two solutions, and all three.
The research, which analyzed more than a million procedures from January 2015 to March 11, 2021, found that merging all three approaches issued the biggest reduction of up to 7.8 million milliliters, or 83 percent. Some hospitals and health systems have already rationed their dye usage.
In the U.S., more than 50 million scans are dependent on contrast dye annually to detect cancer and other diseases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.